Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8305837 | Biochimie | 2014 | 7 Pages |
Abstract
l-Histidinol dehydrogenase from Brucella suis (BsHDH) is an enzyme involved in the histidine biosynthesis pathway which is absent in mammals, thus representing a very interesting target for the development of anti-Brucella agents. In this paper we report the crystallographic structure of a mutated form of BsHDH both in its unbound form and in complex with a nanomolar inhibitor. These studies provide the first structural background for the rational design of potent HDH inhibitors, thus offering new hints for clinical applications.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Katia D'ambrosio, Marie Lopez, Nina A. Dathan, Safia Ouahrani-Bettache, Stephan Köhler, Giuseppina Ascione, Simona Maria Monti, Jean-Yves Winum, Giuseppina De Simone,